Study of effect of gabapentin on persistent pain after open inguinal hernia repair

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN88541159

Enrollment

Registered

2003-09-12

Start date

2000-05-31

Completion date

Unknown

Last updated

2016-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inguinal hernia Digestive System Inguinal hernia

Interventions

Randomised controlled trial: gabapentin at a dose of 900 - 1800 mg per day.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 16 subjects, 16 controls

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

Measure	Time frame
Not provided at time of registration	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026